Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

Neurology

Volumn 47, Issue 2, 1996, Pages 462-466

  Albin, R L ^a,b   Minoshima, S ^a   D'Amato, C J ^a   Frey, K A ^a   Kuhl, D A ^a   Sima, A A F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Neuroscience Laboratory Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BRAIN METABOLISM; CONTROLLED STUDY; DEMENTIA; HUMAN; LEWY BODY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOMATOSENSORY CORTEX;

EID: 0029788124     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.2.462     Document Type: Article

References (35)

1. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993;60:456-463.
2. Perry PH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. J Neurol Sci 1990;95:119-139.
3. Byrne J, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-717.
4. Gibb RG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-1153.
5. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-191.
6. Sima AAF, Clark AW, Sternberger NA, Sternberger LA. Lewy body dementia without Alzheimer changes. Can J Neurol Sci 1986;13:490-497.
7. Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528.
8. Lennox G, Lowe J, Landon M, Byrne E, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-1247.
9. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-654.
10. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
11. McKeith IG, Fairbairn AF, Bothwell RA, et al. Evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
12. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomical standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
13. 18F]FDG. J Nucl Med 1995;36:1238-1248.
14. Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer's disease: a reference region for functional brain image analysis. J Comput Assist Tomogr 1995;19:541-547.
15. Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RJ. Alternative approach to single scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 1984;4:35-40.
16. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme, 1988.
17. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895.
18. Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990;1:156-164.
19. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
20. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52:67-71.
21. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
22. Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimaya A. Positron emission tomography studies in dementia. J Neurol Sci 1993;114:1-6.
23. Hof PR, Bouras C, Constantinidis J, Morrison JH. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990;49:168-184.
24. Hof PR, Bouras C, Constantinidis J, Morrison JH. Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res 1989;493:368-375.
25. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993; 43:305-313.
26. Berthier ML, Leiguarda R, Starkstein SE, Sevlever G, Taratuto AL. Alzheimer's disease in a patient with posterior cortical atrophy. J Neurol Neurosurg Psychiatry 1991;54:1110-1111.
27. Kiyosawa M, Bosley TM, Chawluk J, et al. Alzheimer's disease with prominent visual symptoms. Ophthalmology 1989; 96:1077-1086.
28. Pietrini P, Freo U, Grady CL, et al. A longitudinal positron emission tomography study of cerebral glucose metabolism in patients with Alzheimer's disease and prominent visual impairment. Adv Biosciences 1993;87:69-71.
29. Perry EK, McKeith I, Thompson P, et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202.
30. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-88.
31. Dickson DW, Schmidt ML-Y, Lee VM-Y, Zhao ML, Yen S-H, Trojanowski JQ. Immunoreactivity profile of hippocampal CA2/3 neuntes in diffuse Lewy body disease. Acta Neuropathol (Berl) 1994;87:269-276.
32. Harrington CR, Perry RH, Perry EK, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994;5:215-228.
33. Dickson DW, Crystal H, Mattiace LA, et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (Berl) 1989;78:572-584.
34. Perry EK, Marshall E, Thompson P, et al. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. J Neural Transm Park Dis Dement Sect 1993;6:167-177.
35. Smith MC, Mallory M, Hansen LA, Ge N, Masliah E. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuroreport 1995;6:673-676.